BRPI0816364A2 - injetável, solução de injeção e kit de preparação da injeção - Google Patents

injetável, solução de injeção e kit de preparação da injeção

Info

Publication number
BRPI0816364A2
BRPI0816364A2 BRPI0816364A BRPI0816364A BRPI0816364A2 BR PI0816364 A2 BRPI0816364 A2 BR PI0816364A2 BR PI0816364 A BRPI0816364 A BR PI0816364A BR PI0816364 A BRPI0816364 A BR PI0816364A BR PI0816364 A2 BRPI0816364 A2 BR PI0816364A2
Authority
BR
Brazil
Prior art keywords
injection
solution
preparation kit
kit
injection solution
Prior art date
Application number
BRPI0816364A
Other languages
English (en)
Inventor
Akiko Miyoshi
Masato Ota
Teruhisa Yoshizawa
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Publication of BRPI0816364A2 publication Critical patent/BRPI0816364A2/pt
Publication of BRPI0816364B1 publication Critical patent/BRPI0816364B1/pt
Publication of BRPI0816364B8 publication Critical patent/BRPI0816364B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BRPI0816364A 2007-09-04 2008-09-03 solução de injeção, preparação de kit de injeção e injetável para preparar solução de injeção BRPI0816364B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007-228516 2007-09-04
JP2007228516 2007-09-04
PCT/JP2008/065865 WO2009031577A1 (ja) 2007-09-04 2008-09-03 注射剤、注射液および注射用キット製剤

Publications (3)

Publication Number Publication Date
BRPI0816364A2 true BRPI0816364A2 (pt) 2015-09-29
BRPI0816364B1 BRPI0816364B1 (pt) 2020-10-13
BRPI0816364B8 BRPI0816364B8 (pt) 2021-05-25

Family

ID=40428891

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0816364A BRPI0816364B8 (pt) 2007-09-04 2008-09-03 solução de injeção, preparação de kit de injeção e injetável para preparar solução de injeção

Country Status (10)

Country Link
US (1) US8227430B2 (pt)
EP (1) EP2184066B1 (pt)
JP (1) JP4456177B2 (pt)
KR (1) KR101511398B1 (pt)
CN (1) CN101795694B (pt)
BR (1) BRPI0816364B8 (pt)
ES (1) ES2439497T3 (pt)
HK (1) HK1142820A1 (pt)
MX (1) MX2010001263A (pt)
WO (1) WO2009031577A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102614118B (zh) * 2012-03-15 2014-04-30 北京协和药厂 注射用盐酸表柔比星制剂的制备方法及制剂
CN108159005B (zh) * 2012-04-09 2021-03-23 日本迈科洛生物制药有限公司 注射剂用组合物
JP7001454B2 (ja) 2017-12-18 2022-01-19 日本化薬株式会社 ホスアプレピタントを含有する医薬製剤
LU101511B1 (en) * 2019-12-02 2021-06-04 Herrera Arturo Solis (S)-3-[1-Methylpyrrolidin-2-yl]pyridine, analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a parenteral administration and a process for the preparation of an injectable substance

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB485569A (en) * 1936-11-17 1938-05-17 Ig Farbenindustrie Ag Process for the manufacture of stable solutions of the polyoxyalkylisoalloxazines
JPS58105917A (ja) 1981-12-21 1983-06-24 Toa Eiyou Kagaku Kogyo Kk イソソルビド硝酸エステル溶液
GB8426672D0 (en) 1984-10-22 1984-11-28 Erba Farmitalia Pharmaceutical compositions
EP1283044A3 (en) * 1986-12-05 2003-05-14 Pharmacia Italia S.p.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US4875311A (en) * 1988-04-20 1989-10-24 Sun Room Designs, Inc. Beam construction
JP2919112B2 (ja) 1991-05-13 1999-07-12 武田薬品工業株式会社 セファロスポリン注射剤およびその製造法
JP2915252B2 (ja) 1993-06-30 1999-07-05 明治製菓株式会社 溶解性が改善された製剤の製造法
TW280770B (pt) * 1993-10-15 1996-07-11 Takeda Pharm Industry Co Ltd
JPH09124503A (ja) 1995-10-27 1997-05-13 L T T Kenkyusho:Kk アミチアマイシン類の注射用の抗菌性組成物
JP2000212088A (ja) 1999-01-27 2000-08-02 Kobayashi Kako Kk 難溶性抗ウイルス剤の水溶液
KR100405161B1 (ko) 2000-12-14 2003-11-12 신풍제약주식회사 록소프로펜 함유 근육주사제 조성물
US6881726B2 (en) * 2001-12-24 2005-04-19 Dow Pharmaceutical Sciences Aqueous compositions containing metronidazole
JP2003261449A (ja) 2002-03-05 2003-09-16 Nisshin Oillio Ltd ファモチジン含有水性注射剤およびその製造法
JP2004010479A (ja) * 2002-06-03 2004-01-15 Japan Science & Technology Corp ブロック共重合体とアンスラサイクリン系抗癌剤を含む新規固型製剤及びその製造法
JP2004051526A (ja) 2002-07-18 2004-02-19 Nippon Shokubai Co Ltd 多価フェノールの製造方法
EP1695973A1 (en) * 2005-02-24 2006-08-30 Neuro3D Ocaperidone salt and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
ES2439497T3 (es) 2014-01-23
HK1142820A1 (en) 2010-12-17
EP2184066A1 (en) 2010-05-12
BRPI0816364B8 (pt) 2021-05-25
JPWO2009031577A1 (ja) 2010-12-16
EP2184066B1 (en) 2013-11-06
KR20100051694A (ko) 2010-05-17
JP4456177B2 (ja) 2010-04-28
BRPI0816364B1 (pt) 2020-10-13
CN101795694B (zh) 2012-10-10
US20100173862A1 (en) 2010-07-08
EP2184066A4 (en) 2012-08-01
CN101795694A (zh) 2010-08-04
KR101511398B1 (ko) 2015-04-24
MX2010001263A (es) 2010-10-04
WO2009031577A1 (ja) 2009-03-12
US8227430B2 (en) 2012-07-24

Similar Documents

Publication Publication Date Title
BRPI0918122A2 (pt) molécula de diaboy, diaboy, e mólecula dart
BRPI0807908A2 (pt) Melhoramentos em composições medicinais.
BRPI0909770A2 (pt) Vacina, e, kit
ATE513831T1 (de) Pyridinä3,4-büpyrazinone
BRPI0906962A2 (pt) Composto, e, composição farmacêutica
BRPI0906556A2 (pt) Composto, e, composição farmacêutica
BRPI0905369A2 (pt) Composição farmacêutica, composição e kit compartimentado
DE602007011183D1 (de) Hydrazinfunktionalisiertes Polymer
DK2125048T3 (da) Præparat
BRPI0905715A2 (pt) Composição farmacêutica e kit de componentes
BRPI0917681A2 (pt) Composto, e, composição farmacêutica
FR2903692B1 (fr) Sulfonylimidures aromatiques et leur preparation.
NO2022038I1 (no) ropeginterferon alfa-2b
DE112008000295A5 (de) Steckerstift
BRPI0914182A2 (pt) composto, e, composição farmacêutica
DE502007002482D1 (de) Injektor
BRPI0816364A2 (pt) injetável, solução de injeção e kit de preparação da injeção
FR2919373B1 (fr) Raccord rapide perfectionne.
FR2925319B1 (fr) Composition cosmetique tenseur.
ES1062273Y (es) Butaca perfeccionada
FR2903930B3 (fr) Vrille
BRPI0911722A2 (pt) conjugado de peptídeo-polímero
FR2935896B1 (fr) Prothese discale en polyetherethercetone.
IT1395022B1 (it) Kit da costruzione.
FR2899452B1 (fr) Gondole contreventee

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: MEIJI SEIKA PAHRMA CO., LTD. (JP)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 13/10/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/09/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 15A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2738 DE 27-06-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.